Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oriana H Y Yu

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Epidemiology (Cambridge, Mass.)|April 8, 2022
Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients With Type 2 DiabetesSally Lu, Hui Yin, Oriana H Y Yu, et al.
Drug Safety|December 16, 2019
The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort StudyRicheek Pradhan, Hui Yin, Oriana H Y Yu, et al.
Diabetes Care|July 22, 2022
Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 DiabetesRicheek Pradhan, Hui Yin, Oriana H Y Yu, et al.
BMJ Open Diabetes Research & Care|November 10, 2023
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort studyRicheek Pradhan, Oriana H Y Yu, Robert W Platt, et al.
British Journal of Clinical Pharmacology|March 13, 2024
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetesSamantha B Shapiro, Hui Yin, Oriana H Y Yu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 25, 2023
Glucagon like peptide-1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population-based cohort studyRicheek Pradhan, Oriana H Y Yu, Robert W Platt, et al.
Drug Safety|May 8, 2024
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort StudySamantha B Shapiro, Hui Yin, Oriana H Y Yu, et al.
Annals of Internal Medicine|July 14, 2025
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes : A Population-Based Cohort StudyYunha Noh, Hui Yin, Oriana H Y Yu, et al.
American Journal of Epidemiology|May 31, 2019
Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset HypogonadismChristina Santella, Christel Renoux, Hui Yin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2021
Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003-2018Vanessa C Brunetti, Oriana H Y Yu, Robert W Platt, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Epidemiology (Cambridge, Mass.)|April 8, 2022
Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients With Type 2 DiabetesSally Lu, Hui Yin, Oriana H Y Yu, et al.
Drug Safety|December 16, 2019
The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort StudyRicheek Pradhan, Hui Yin, Oriana H Y Yu, et al.
Diabetes Care|July 22, 2022
Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 DiabetesRicheek Pradhan, Hui Yin, Oriana H Y Yu, et al.
BMJ Open Diabetes Research & Care|November 10, 2023
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort studyRicheek Pradhan, Oriana H Y Yu, Robert W Platt, et al.
British Journal of Clinical Pharmacology|March 13, 2024
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetesSamantha B Shapiro, Hui Yin, Oriana H Y Yu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 25, 2023
Glucagon like peptide-1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population-based cohort studyRicheek Pradhan, Oriana H Y Yu, Robert W Platt, et al.
Drug Safety|May 8, 2024
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort StudySamantha B Shapiro, Hui Yin, Oriana H Y Yu, et al.
Annals of Internal Medicine|July 14, 2025
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes : A Population-Based Cohort StudyYunha Noh, Hui Yin, Oriana H Y Yu, et al.
American Journal of Epidemiology|May 31, 2019
Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset HypogonadismChristina Santella, Christel Renoux, Hui Yin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2021
Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003-2018Vanessa C Brunetti, Oriana H Y Yu, Robert W Platt, et al.
Pageof 5